Avanos Medical Q2 Adj. EPS $0.24 Misses $0.30 Estimate, Sales $169.40M Miss $186.22M Estimate
Portfolio Pulse from Benzinga Newsdesk
Avanos Medical (NYSE:AVNS) reported Q2 adjusted earnings of $0.24 per share, missing the analyst consensus estimate of $0.30 by 20%. This is a 41.46% decrease from the same period last year. The company also reported quarterly sales of $169.40 million, missing the analyst consensus estimate of $186.22 million by 9.03%. This is a 16.55% decrease from the same period last year.
August 09, 2023 | 11:04 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Avanos Medical's Q2 earnings and sales missed estimates, marking a significant decrease from the same period last year.
Avanos Medical's earnings and sales for Q2 significantly missed estimates, which is likely to negatively impact investor sentiment and potentially lead to a decrease in the company's stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100